Latest Strategic Expansion News

Hiremii Limited has landed its initial paying customers for its AI-powered workforce intelligence platform, marking a pivotal step in its shift from recruitment services to a SaaS technology provider in energy and infrastructure sectors.

Evolution Mining (ASX: EVN) ended March 2026 with a net cash position of $42 million and a $1.37 billion cash balance, driven by strong cash flow from high-margin operations and on-track production.

Yancoal Australia is set to acquire an 80% stake in the Kestrel Coal Mine for US$1.85 billion upfront plus up to US$550 million in contingent payments, significantly boosting its metallurgical coal portfolio and production scale in Queensland.

Atomos Limited is acquiring Flanders Scientific to deepen its foothold in professional reference monitors, funded by a new $10 million CBA loan. The deal is immediately earnings accretive and broadens Atomos’ video production ecosystem.

Champion Iron has finalized its US$300 million acquisition of Norwegian iron ore producer Rana Gruber, securing over 92% ownership and setting sights on full integration and delisting. The deal enhances Champion's high-purity iron ore portfolio and strengthens its position in the green steel supply chain.

Rapid Critical Metals Ltd has acquired an 80% interest in Green Copper Pty Ltd, gaining control of the Tooloom Silver Project in northern New South Wales. The acquisition adds a large, historically productive silver district with multiple high-grade targets, complementing Rapid's existing NSW assets.

Zinc of Ireland NL (ASX: ZMI) has entered a binding agreement to acquire Dutch metals technology company Meclex, integrating proprietary hydrometallurgical processes ARGO and VOLTA with its Kildare Zinc project. The company also announced a $5.5 million placement to support exploration and technology development alongside new board appointments.

De.mem Limited has responded to an ASX query regarding the late lodgement of an Appendix 3Y for director Andreas Hendrik De Wit, attributing the delay to an administrative oversight. The company has outlined existing compliance protocols and introduced additional measures to prevent future lapses.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Way2VAT has successfully raised A$2.6 million through a share placement, aiming to repay short-term debt and fund its strategic expansion plans. Investors have shown strong support, agreeing to a six-month escrow on their shares.

Ore Resources has completed three strategic acquisitions, significantly enlarging its gold exploration tenure in Western Australia's Eastern Goldfields and setting the stage for an extensive drilling campaign in 2026.

Lithium Universe Limited appoints Iggy Tan as full-time CEO and Executive Chairman, signalling a strategic push to fast-track lithium refinery projects and innovative recycling technologies.